All are true state statements about malignant hypehermia except
**Core Concept**
Malignant hyperthermia (MH) is a rare but life-threatening medical emergency that occurs in response to certain volatile anesthetics and depolarizing muscle relaxants, leading to a hypermetabolic state and muscle rigidity. It is characterized by an abnormality in the ryanodine receptor type 1 (RyR1) gene, which regulates calcium release from the sarcoplasmic reticulum.
**Why the Correct Answer is Right**
Malignant hyperthermia is caused by a genetic mutation in the RyR1 gene, leading to an abnormal release of calcium ions from the sarcoplasmic reticulum. This results in an uncontrolled increase in muscle contraction and heat production, ultimately leading to muscle rigidity, hyperthermia, and multi-organ failure if left untreated. The condition is triggered by exposure to volatile anesthetics, such as halothane, isoflurane, and sevoflurane, and depolarizing muscle relaxants, like succinylcholine.
**Why Each Wrong Option is Incorrect**
**Option A:** This statement is incorrect because malignant hyperthermia is not caused by a deficiency in pyruvate dehydrogenase (PDH) enzyme. While PDH deficiency is a metabolic disorder that affects energy production in the brain, it is not directly related to the pathophysiology of malignant hyperthermia.
**Option B:** This statement is incorrect because succinylcholine is a depolarizing muscle relaxant that can trigger malignant hyperthermia in susceptible individuals. It is not a safe alternative for patients at risk of MH.
**Option C:** This statement is incorrect because dantrolene is the specific antidote for malignant hyperthermia, not a muscle relaxant. It works by inhibiting calcium release from the sarcoplasmic reticulum and reducing muscle contraction.
**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia is a diagnosis of exclusion, and a high index of suspicion is required to identify at-risk patients. A family history of MH, previous episodes of MH, or a history of anesthesia-related complications increase the risk of developing MH.
**Correct Answer: A.**